Trial Information
Summary: A Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients
A Randomized, Double-Blind, Parallel-Group Study of
Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthrits
Patients with or at High Risk for Cardiovascular Disease. This
study is using an oral medication that has already been FDA
approved.
Patient Inclusion Criteria
- Male or Female age 18 and older.
- A diagnosis of Osteoarthritis or Rheumatoid Arthritis has been
determined for at least 6 months.
- With an established risk or high risk for Cardiovascular
disease.
Patient Exclusion Criteria
- If patient has had acute joint trauma.
- If the patient is taking an anticoagulant or lithium.
|
Contact:
Brenda, Document Specialist
Wichita Clinic, PA
3311 E. Murdock
Wichita, KS 67208
Telephone: 316-689-9542
Fax: 316-689-9694
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:32:00 AM